Date | Saturday, April 22, 2023
Location
USF Health Center for Advanced Medical Learning and Simulation (CAMLS)
124 S Franklin Street
Tampa, FL 33602
Audience
GI Specialists and Primary Care Physicians
Learning Objectives
As a result of participating in this activity, learners should be able to:
- Review Eosinophilic Esophagitis
- Compare and contrast the efficacy of different medical treatment approaches.
- Analyze indications and possible surgical treatment options for GERD to esophageal cancer.
- Recall the disease states of Inflammatory Bowel Disease including Ulcerative Colitis and Crohn’s Disease, including current placement and beyond across private practice, community hospitals and academic environments.
- Determine surgical intervention indications for colon and rectal disease, interpreting the benefits and outcomes for robotic colon and rectal surgery.
- Summarize various disease processes that are treatable by EUS and the efficacy of current approaches versus interventional EUS procedures.
- Discuss how to apply a practical interdisciplinary approach to digestive disease intervention.
- Explain Gastroparesis diagnosis and management as well as surgical interventions available for treatment.
- Illustrate current medical management for chronic and acute pancreatitis as well as endoscopic and surgical interventions for disease management.
- Identify best practice for bariatric procedures.
- Outline patient benefits of robotic assisted surgery in modern hernia repair.
Relevant Financial Relationships
Prior to the activity, USF Health will disclose and mitigate all relevant financial relationships that relate to the content of the activity.
Accreditation
Continuing education activity credit provided by USF Health
Physicians
ACCME:
USF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
USF Health designates this live activity for a maximum of 5.5AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians
Florida Board of Medicine:
USF Health is an approved provider of continuing education for physicians through
the Florida Board of Medicine. This activity has been reviewed and approved for
5.5 continuing education credits.
Nurses
Florida Board of Nursing:
USF Health (provider number 2970) is an approved provider of continuing education for nurses through Florida Board of Nursing. This activity has been approved for 5.5 contact hours.
Physician Assistants
Florida Physician Assistant Continuing Education Credit:
USF Health is an approved provider (50-2970) of Florida Physician Assistant continuing education credit through the Florida Board of Medicine. This activity has been approved for 5.5 continuing education credits.
Osteopathy
Florida Board of Osteopathic Medicine:
USF Health is an approved provider of continuing education for physicians through the Florida Board of Osteopathic Medicine. This activity has been reviewed and approved for up to 5.5 continuing education credits.
Disclaimer
The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options for a specific patient’s medical condition.
Questions
If you have continuing education questions, please contact USF Health at cpdsupport@usf.edu
Presenters
|
Allen P. Chudzinski, MD, FACS, FASCRS |
Salvatore Docimo, Jr., DO, FACS
|
Christopher DuCoin, MD |
|
Rene D. Gomez-Esquivel, MD |
Jonathan Hilal, MD
|
John Jacobs, MD
|
|
Rebecca Klam, PsyD
|
Ashley Mooney, MD Assistant Professor of Surgery |
Timothy Nywening, MD
|
|
Adham R Saad, MD FACS |
Jennifer Seminerio, MD Director of Inflammatory Bowel Disease
|
Joseph Sujka, MD
|
 Pushpak Taunk, MD |
Agenda
7:15 a.m. - 8:00 a.m. | Registration – Continental Breakfast
8:00 a.m. – 8:15 a.m. | Welcome & Introductions
8:15 a.m. – 8:35 a.m. | Eosinophilic Esophagitis: Management and Updates
John Jacobs, MD
This session will discuss the epidemiology and the classic endoscopic findings in EoE, the importance of treating both the inflammatory and fibrostenotic components of EoE and compare the efficacy of the different medical treatment approaches in EoE.
8:35 a.m. – 8:55 a.m. | GERD to Esophageal Cancer
Christopher DuCoin, MD
30% of the US population has Gastroesophageal Reflux Disease (GERD). While many are symptomatic, most will thankfully not progress to esophageal cancer. This session will review indications and possible surgical treatment options for GERD. We will then shift and discuss the current endoscopic and surgical treatments for esophageal cancer. The discussion will include the process of working up an esophageal cancer patient and explaining the importance of chemotherapy, radiation therapy, and immunotherapy - all in conjunction with operative interventions.
8:55 a.m. – 9:15 a.m. | USF Inflammatory Bowel Disease Center: Updates and Future Goals
Jennifer Seminerio, MD
The objective is to discuss the disease state of Inflammatory Bowel Disease including Ulcerative Colitis and Crohn's Disease and their current placement in 2022 and beyond, in private practice, community hospitals and academic environments. There will be a synopsis of where USF plans to position itself regionally and nationally within this arena by discussing the USF IBD Center, which is currently under construction, along with the goals of the IBD Division as an entity here at USF. We will conclude by discussing the importance of advocacy in the state of Florida within this disease state, ways in which we can collaborate together and build a better future for these patients.
9:15 a.m. - 9:25 a.m. | Panel Q&A (Jacobs, DuCoin, Seminerio)
9:25 a.m. - 9:45 a.m. | Robotic Colon and Rectal Surgery
Allan Chudzinski, MD
In this session, Dr. Chudzinski will discuss when surgical intervention is indicated for colon and rectal disease, the benefits of robotic surgery and benefits and outcomes from robotic colon and rectal surgery.
9:45 a.m. - 10:05 a.m. | Innovations in Interventional EUS
Pushpak Taunk, MD
In this session, we will discuss the various disease processes that are treatable by EUS, the efficacy of interventional EUS procedures and compare the efficacy of current approaches versus interventional EUS procedures.
10:05 a.m. - 10:25 a.m. | Psychogasteroenterology: The Brain-Gut Connection
Rebecca Klam, PsyD
What is phsychogastreoenterology and what do we know about the brain-gut connection? We will explore that and understand how we can use a practical interdisciplinary approach to digestive disease intervention in this session.
10:25 a.m. - 10:35 a.m. | Panel Q&A (Chudzinski, Taunk, Klam)
10:35 a.m. – 10:50 a.m. | Break
10:50 a.m. - 11:10 a.m. | Gastroparesis
Joseph Sujka, MD
In this talk, we will discuss the diagnosis of Gastroparesis - how this diagnosis is made, what the subtypes are and what treatments are available. We will also discuss ways to facilitate a team-based approach for treatment of these patients and what proposed benefits this may offer patients.
11:10 a.m. - 11:30 a.m. | Acute Pancreatitis & Pancreatic Cysts
Renee Gomez-Esquivel, MD
This presentation will describe the current medical management of acute pancreatitis. Will describe the complications of this disease including pseudocyst and wall off necrosis. And finally will discuss the timing and the endoscopic management of these complications.
11:30 a.m. - 11:50 a.m. | Surgical Management for Benign Pancreatic Disease
Timothy Nywening, MD
Overview of surgical management of benign pancreatic disease including cystic lesions and chronic pancreatitis.
11:50 a.m. - 12:00 p.m. | Panel Q&A (Sujka, Gomez-Esquivel, Nywening)
12 p.m. – 12:45 p.m. | Lunch
12:45 p.m. – 1:05 p.m. | Chronic Pancreatitis: Evaluation & Management
Jonathan Hilal, MD
Review of chronic pancreatitis and the latest on medical & endoscopic management of chronic pancreatitis.
1:05 p.m. – 1:25 p.m. | The Process Towards Weight Loss Surgery
Ashley Mooney, MD
This session will discuss the types of bariatric surgery and the mechanism behind weight loss. Topics discussed will include improvement in co-morbidity conditions, potential complications after surgery and what it means to be a Accredited Comprehensive Center of Excellence.
1:25 p.m. – 1:45 p.m. | Bariatric Endoscopy: From Complications to Primary Weight Loss Procedures
Salvatore Docimo Jr., MD
In the past decade, new bariatric endoscopic procedures have been developed for people who are not candidates for weight loss surgery or those who prefer a less invasive, non-surgical alternative. It has also become an important tool for evaluation, diagnosis and management of complications of bariatric surgery. This session will provide an overview of bariatric endoscopy, its use for treating bariatric surgery complications and as a non-surgical primary procedure for weight loss.
1:45 p.m. – 2:05 p.m. | Robotic Surgery in Hernia Repair
Adham Saad, MD
There have been monumental advances in our ability to fix complex hernias. A large component of this is the capabilities robotic assisted surgery affords. It allows access to surgical planes that are difficult to attain with open or laparoscopic surgery with huge benefits in patient satisfaction and length of stays.
2:05 p.m. – 2:15 p.m. | Panel Q&A (Hilal, Mooney, Docimo, Saad)
2:15 p.m. – 2:30 p.m. | Closing Remarks
2:30 p.m. - 3:15 p.m. | Networking and Cocktail Reception